menu search

Ultragenyx launches evkeeza® (evinacumab for injection) in canada for the treatment of homozygous familial hypercholesterolemia (hofh)

evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (...

September 25, 2023, 9:13 pm

Regeneron (regn) gets label extension for cholesterol drug

Regeneron (REGN) gets FDA approval for evkeeza to treat children aged 5 to 11 with homozygous familial ...

March 22, 2023, 4:01 pm

Regeneron's (regn) sbla for evkeeza gets fda priority review

The FDA accepts for priority review Regeneron's (REGN) sBLA for evkeeza for treating children aged five...

December 1, 2022, 9:47 am


Search within

Pages Search Results: